Smruthi Organics Limited has formally received the Brazilian Good Manufacturing Practices (GMP) Certificate, specifically the Certificado de Boas Praticas de Fabricagdo (CBPF), from the Brazilian Health Regulatory Agency (ANVISA). This follows the company's earlier intimation regarding the inspection report dated 8th October 2026.
The certificate was issued pursuant to Resolution RE No. 4,179 dated 22nd October 2026, which was published in the Official Gazette of Brazil on 26th October 2026. It certifies compliance with Good Manufacturing Practices for the active pharmaceutical ingredient Levanlodipine Besylate Hemipentahydrate manufactured at the company's Unit II situated at Chincholi, Solapur, Maharashtra.
The certificate is valid until 26th October 2028, providing a two-year validity period from the date of publication in the official gazette.
The company describes this achievement as "an important milestone" in its efforts towards strengthening regulatory approvals and expanding its presence in the Brazilian pharmaceutical market.
This disclosure is made for information and record purposes to the Corporate Relation Department of BSE Limited and the Listing Department of Metropolitan Stock Exchange of India Ltd.